5 Pharmaceutical Stocks to Buy According to Peter Kolchinsky’s RA Capital

4. Adagio Therapeutics, Inc. (NASDAQ:ADGI)

RA Capital Management’s Stake Value: $225 million

Percentage of RA Capital Management’s 13F Portfolio: 3.12%

Number of Hedge Fund Holders: 12

Adagio Therapeutics, Inc. (NASDAQ:ADGI) is a young American company founded in 2020 that aims to develop antibody-based treatments for infectious diseases. The company is currently developing a treatment for Covid-19.

Dr. Kolchinsky’s RA Capital held 5.3 million Adagio Therapeutics, Inc. (NASDAQ:ADGI) shares by the end of this year’s third quarter. These were worth $225 million and represented 3.12% of its portfolio.

Adagio Therapeutics, Inc. (NASDAQ:ADGI) earned -$0.98 in GAAP EPS during its third quarter, missing analyst estimates.